1.2200
22-十一月-24 16:44:58
15 分钟延时
股票
+0.0300
+2.52%
今日范围
1.1700 - 1.2300
ISIN
N/A
来源
NASDAQ
Atossa Completes Enrollment of Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer
12 6月 2023 09:15:00 条件 Nasdaq GlobeNewswire
Atossa Appoints Life Sciences Financial and Operations Industry Veteran Greg Weaver as Chief Financial Officer
01 6月 2023 09:10:00 条件 Nasdaq GlobeNewswire